Authors:
GOLDSTEIN D
HERTZOG P
TOMKINSON E
COULDWELL D
MCCARVILLE S
PARRISH S
CUNNINGHAM P
NEWELL M
OWENS M
COOPER DA
Citation: D. Goldstein et al., ADMINISTRATION OF IMIQUIMOD, AN INTERFERON INDUCER, IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS TO DETERMINE SAFETY AND BIOLOGIC RESPONSE MODIFICATION, The Journal of infectious diseases, 178(3), 1998, pp. 858-861
Authors:
KNOWLES CH
SCOTT SM
LUNNISS PJ
NEWELL M
GARVIE N
WILLIAMS NS
Citation: Ch. Knowles et al., COLONIC SCINTIGRAPHY HIGHLIGHTS DIFFERENCES IN SUBGROUPS OF PATIENTS WITH SLOW-TRANSIT CONSTIPATION, Gastroenterology, 114(4), 1998, pp. 3208-3208
Authors:
NEWELL M
MILLIKEN S
CHIPMAN M
CEBON J
LEWIS C
GOLDSTEIN D
COOPER DA
Citation: M. Newell et al., DOX-SL (STEALTH LIPOSOMAL DOXORUBICIN HCL) MAINTENANCE THERAPY AFTER RESPONSE IN AIDS-RELATED KAPOSIS-SARCOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 15-15
Authors:
MOILANEN T
SCOTT G
NEWELL M
GARVIE N
FREEMAN MAR
Citation: T. Moilanen et al., BONE SCINTIGRAPHIC APPEARANCE OF ASYMPTOMATIC HYDROXYAPATITE-COATED HIP ARTHROPLASTIES, The Journal of arthroplasty, 12(4), 1997, pp. 380-386
Authors:
NEWELL M
GOLDSTEIN D
MILLIKEN S
LEWIS C
HOY J
THOMSON B
COOPER D
Citation: M. Newell et al., PHASE I II TRIAL OF FILGRASTIM (R-METHUG-CSF), CEOP CHEMOTHERAPY AND ANTIRETROVIRAL THERAPY IN HIV-RELATED NON-HODGKINS-LYMPHOMA/, Annals of oncology, 7(10), 1996, pp. 1029-1036
Authors:
NEWELL M
MILLIKEN S
CHIPMAN M
CEBON J
LEWIS C
GOLDSTEIN D
COOPER DA
Citation: M. Newell et al., DOX-SL (STEALTH LIPOSOMAL DOXORUBICIN HCL) MAINTENANCE THERAPY AFTER RESPONSE IN AIDS-RELATED KAPOSIS-SARCOMA, AIDS, 10, 1996, pp. 133-133
Citation: M. Newell, WEIGHT, HEIGHT AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN YOUNG-CHILDREN OF INFECTED MOTHERS (VOL 14, PG 685, 1995), The Pediatric infectious disease journal, 14(11), 1995, pp. 947-947